BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 34705880)

  • 21. P16
    Ishikawa M; Nakayama K; Nakamura K; Yamashita H; Ishibashi T; Minamoto T; Sawada K; Yoshimura Y; Iida K; Razia S; Ishikawa N; Nakayama S; Otsuki Y; Kyo S
    Sci Rep; 2021 Sep; 11(1):18236. PubMed ID: 34521948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantum dot-based immunofluorescent imaging and quantitative detection of TOP2A and prognostic value in triple-negative breast cancer.
    Zheng H; Li X; Chen C; Chen J; Sun J; Sun S; Jin L; Li J; Sun S; Wu X
    Int J Nanomedicine; 2016; 11():5519-5529. PubMed ID: 27799773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers.
    Ghisoni E; Maggiorotto F; Borella F; Mittica G; Genta S; Giannone G; Katsaros D; Sciarrillo A; Ferrero A; Sarotto I; Erriquez J; Di Renzo MF; Aglietta M; Valabrega G
    J Ovarian Res; 2019 Feb; 12(1):17. PubMed ID: 30760286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab.
    Fountzilas G; Christodoulou C; Bobos M; Kotoula V; Eleftheraki AG; Xanthakis I; Batistatou A; Pentheroudakis G; Xiros N; Papaspirou I; Koumarianou A; Papakostas P; Bafaloukos D; Skarlos DV; Kalogeras KT
    J Transl Med; 2012 Oct; 10():212. PubMed ID: 23092535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunohistochemical detection of P16 and HPV L1 capsid protein on cell block sections from residual PapSpin liquid-based gynecology cytology specimens as a diagnostic and prognostic tool.
    Haltas H; Bayrak R; Yenidunya S; Yildirim U
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16(11):1588-95. PubMed ID: 23111976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].
    Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D
    Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The study of the combination detection of HPV-DNA and p16INK4a in cervical lesions.
    Huang MZ; Huang S; Li DQ; Nie XM; Li HB; Jiang XM
    Med Oncol; 2011 Dec; 28 Suppl 1():S547-52. PubMed ID: 21053103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p16 expression in patients with cervical cancer and its prognostic significance: meta-analysis of published literature.
    Huang K; Li LA; Meng YG; Fu XY
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():64-9. PubMed ID: 25461355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of TOP2A, EZH2 and paxillin expression as markers of aggressive breast cancer: relationship with other prognostic factors.
    Panousis D; Patsouris E; Lagoudianakis E; Pappas A; Kyriakidou V; Voulgaris Z; Xepapadakis G; Manouras A; Athanassiadou AM; Athanassiadou P
    Eur J Gynaecol Oncol; 2011; 32(2):156-9. PubMed ID: 21614903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions.
    Shi J; Liu H; Wilkerson M; Huang Y; Meschter S; Dupree W; Schuerch C; Lin F
    Hum Pathol; 2007 Sep; 38(9):1335-44. PubMed ID: 17512033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA topoisomerase II alpha promotes the metastatic characteristics of glioma cells by transcriptionally activating β-catenin.
    Liu Y; Ma J; Song JS; Zhou HY; Li JH; Luo C; Geng X; Zhao HX
    Bioengineered; 2022 Feb; 13(2):2207-2216. PubMed ID: 35012441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UPF1 promotes chemoresistance to oxaliplatin through regulation of TOP2A activity and maintenance of stemness in colorectal cancer.
    Zhu C; Zhang L; Zhao S; Dai W; Xu Y; Zhang Y; Zheng H; Sheng W; Xu Y
    Cell Death Dis; 2021 May; 12(6):519. PubMed ID: 34021129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of ProEXC and PRMT5 in cervical adenocarcinoma and their clinical significance].
    Cui HX; Lou XL; Xia W; Zhang YS; Cheng XY; Deng LF
    Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(48):3967-3971. PubMed ID: 38129175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Type II Diabetes on Tongue Dysplasia and p16-Related Aging Process: An Experimental Study.
    Altun E; Yazici H; Arslan E; Tulaci KG; Erken HA
    Anal Cell Pathol (Amst); 2019; 2019():3563215. PubMed ID: 31687322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenetic Function and Prognostic Value of DNA Topoisomerase II Alpha in Human Malignances: A Pan-Cancer Analysis.
    Zhao F; Chang J; Zhao P; Wang W; Sun X; Ma X; Yin M; Wang Y; Yang Y
    Front Genet; 2022; 13():856692. PubMed ID: 35873470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of significant genes signatures and prognostic biomarkers in cervical squamous carcinoma via bioinformatic data.
    He Y; Hu S; Zhong J; Cheng A; Shan N
    PeerJ; 2020; 8():e10386. PubMed ID: 33344075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sun-Exposed versus Sun-Protected Cutaneous Basal Cell Carcinoma: Clinico-Pathological Profile and p16 Immunostaining.
    Hasan A; Kandil AM; Al-Ghamdi HS; Alghamdi MA; Nasr M; Naeem SA; Abd-Elhay WM; Mohamed OKE; Ibrahim HSA; Ahmed EM; Abdrabo AEM; Elgohary SA
    Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Efficiency of Dyes in Detection of Cancer Cells: An Original Research.
    Ravindranath KV; Karpe T; Gabhale SD; Dutta SD; Tiwari RVC; Javed MQ; Tiwari HD
    J Pharm Bioallied Sci; 2022 Jul; 14(Suppl 1):S182-S184. PubMed ID: 36110771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between serum P16ink4A concentration and CIN and cervical cancer among women attending a cervical cancer clinic in western Uganda: A case control study.
    Ssedyabane F; Ngonzi J; Tusubira D; Nambi Najjuma J; Kajabwangu R; Okeny C; Nuwashaba D; Namuli A; Niyonzima N
    Gynecol Oncol Rep; 2024 Jun; 53():101388. PubMed ID: 38590932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herpes Simplex Virus, Human Papillomavirus, and Cervical Cancer: Overview, Relationship, and Treatment Implications.
    Sausen DG; Shechter O; Gallo ES; Dahari H; Borenstein R
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.